close
randox logo
  • home Home

  • linked_services Solutions keyboard_arrow_down

  • experiment Services keyboard_arrow_down

  • support Support & Resources keyboard_arrow_down

  • apartment Company keyboard_arrow_down

  • mail Contact

randox logo
  • Solutions
    keyboard_arrow_down
  • Services
    keyboard_arrow_down
  • Support & Resources
    keyboard_arrow_down
  • Company
    keyboard_arrow_down
  • Contact
Randox Health search menu

Get in touch to discover more

To find out more about the Coeliac Disease Biochips, enquire now.

Screening for IgA antibodies to tissue transglutaminase (Anti-tTG IgA) and IgG antibodies to tissue transglutaminase (Anti-tTG IgG) can provide insight into a patient’s response to foods like gluten, often checked when identifying food sensitivities or autoimmune conditions, such as coeliac disease.

Applications

  • Primary Care GPs
  • Hospital Labs
  • Gastroenterology Departments

Anti-tTG IgA Biochip

Anti-tTG IgA are used as the preferred test for screening of coeliac disease and dermatitis herpetiformis, being highly (>90%) sensitive and specific. There is a good correlation between anti-tTG antibody and disease activity. Relapse or poor compliance with a gluten-free diet is often associated with the return of antibody positivity.

humidity_low Sample Type:
Serum

update Time to Result:
40 Minutes

labs Sample Volume:
230 µL

Anti-tTG IgG Biochip

Coeliac disease is often associated with IgA deficiency, a common immunodeficiency found in around 1 in 500 of our population. IgA levels are estimated in all patients with suspected coeliac disease. As such, IgA-deficient individuals with suspected coeliac disease are tested for Anti-tTG IgG to aid in diagnosis

humidity_low Sample Type:
Serum

update Time to Result:
40 Minutes

labs Sample Volume:
230 µL

Benefits of the Evidence MultiSTAT

ward Improved Triage

Using biomarker data would improve triage, reduce or defer referral, fast track patients identified as 'high risk', and reduce healthcare burden.

savings Save Hospital Resources

With results from a single sample patients can avoid taking unnecessary and invasive tests

data_array Better Patient Care

Biochip results and refined data-based analysis accelerates medical decisions.

The Evidence MultiSTAT

The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.

Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.

With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.

MultiSTAT Cartridge

The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.

The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.

No other components are required.